Why the study?
How should dual antiplatelet therapy be managed in patients with coronary stents undergoing surgical procedures to balance the risk of stent thrombosis and bleeding?
How should dual antiplatelet therapy be managed in patients with coronary stents undergoing surgical procedures to balance the risk of stent thrombosis and bleeding?
This review provides an overview of perioperative management strategies for patients with coronary stents to balance the risks of stent thrombosis and bleeding.
May support guideline-based perioperative DAPT strategies in stented patients; leaves open optimal risk balancing pending prospective trials.
Percutaneous coronary intervention with stent placement is one of the most frequently performed procedures in the western world. Patients with coronary stents need to be on dual antiplatelet therapy in order to minimize the risk of stent thrombosis. When these patients undergo surgical procedures, the risk of stent thrombosis needs to be balanced against the risk of bleeding in the perioperative period. We review the definition of stent thrombosis and its incidence, the perioperative risk factors associated with stent thrombosis and with bleeding owing to dual antiplatelet therapy. Based on the published guidelines, we also review different management strategies of patients with coronary stents, or who develop stent thrombosis in the perioperative period. We also present some future perioperative management strategies, illustrating the possibilities and challenges offered by newer antiplatelet agents.
No takes yet. Share an insight, caveat, or question.
Raza et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: